Tripartite motif-containing 51J, pseudogene (TRIM51JP)

Tripartite motif-containing 51J, pseudogene (TRIM51JP) is annotated as a **pseudogene**, meaning it is a non-protein-coding genomic element with sequence similarity to the functional TRIM51 gene but is generally considered noncoding and lacks normal protein-coding function[3][7]. Pseudogenes are typically unable to produce functional protein due to disabling mutations, but recent research suggests some can be transcribed and may produce regulatory RNAs that affect the expression of their parent gene or other genes[1][8]. There is currently no evidence that TRIM51JP acts as a conventional therapeutic target such as a receptor, enzyme, transporter, or ion channel. There are also no established drugs targeting this pseudogene, nor is it recognized as a biomarker or as playing a defined safety role. Its importance, if any, likely derives from possible regulatory functions at the RNA level observed in pseudogenes generally, not from any unique or well-characterized function of TRIM51JP itself. Notably, this entity is not the protein-coding gene TRIM51 (Tripartite motif-containing 51), which is a ubiquitin ligase involved in innate immune response and gene expression regulation, and which has its own aliases, annotations, and possible relevance as a protein target[4][6]. If your interest is in the protein-coding form, TRIM51, not TRIM51JP (the pseudogene), you should search for "Tripartite motif-containing 51" or "TRIM51" without the "J, pseudogene" suffix. In summary, **TRIM51JP is a pseudogene, not a protein-coding therapeutic target, and there is no evidence for drug interactions, disease mechanisms, or protein function for this entity at this time**. The entry is included here only as a genomic element, not as an actionable biomedical target[3][7][1][8].